The Priority Review

Tag

Symbicort Aerosphere

1 story

  1. Clinical trials

    AstraZeneca registers Phase 3 trial of Symbicort Aerosphere in children

    The study plans to enroll 216 participants aged 4 to <12 years and start on October 30, 2026. It plans to compare BFF MDI 80/4.8 μg 2 actuations BID to BD MDI 80 μg 2 actuations BID over 6 weeks to assess lung function and safety.